Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer

Clinical trial NCT01076335 · COMPLETED

Trial details

NCT number: NCT01076335
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2005-05-01
Primary completion: 2015-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.